UB Paderborn / Katalog / Suche / in CDI

Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study

Nutrition journal, 2019-02, Vol.18 (1), p.13-13, Article 13

2019

Link zum Volltext

Verfügbarkeit prüfen

Influence of body variables in the development of metabolic syndrome-A long term follow-up study

PloS one, 2018-02, Vol.13 (2), p.e0192751-e0192751

2018

Link zum Volltext

Verfügbarkeit prüfen

Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination ( Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)

Nutrients, 2021-01, Vol.13 (2), p.427

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of a lupin protein concentrate on lipids, blood pressure and insulin resistance in moderately dyslipidaemic patients: A randomised controlled trial

Journal of functional foods, 2017-10, Vol.37, p.8-15

2017

Link zum Volltext

Verfügbarkeit prüfen

Nutraceutical approach to moderate cardiometabolic risk: Results of a randomized, double-blind and crossover study with Armolipid Plus

Journal of clinical lipidology, 2014-01, Vol.8 (1), p.61-68

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation

Frontiers in molecular biosciences, 2022-07, Vol.9, p.925587-925587

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study

Nutrition journal, 2019-09, Vol.18 (1), p.54-54, Article 54

2019

Link zum Volltext

Verfügbarkeit prüfen

Indicators of Cardiovascular Risk in Metabolic Syndrome: Long Term Follow-up in Italian Patients

Current vascular pharmacology, 2017-05, Vol.15 (3), p.248

2017

Link zum Volltext

Verfügbarkeit prüfen

Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary prevention

Journal of clinical lipidology, 2015-03, Vol.9 (2), p.226-233

2015

Link zum Volltext

Verfügbarkeit prüfen

Potential of PCSK9 as a new target for the management of LDL cholesterol

Research reports in clinical cardiology, 2015-01, Vol.6 (default), p.73-86

2015

Link zum Volltext

Verfügbarkeit prüfen

LDL receptor phenotype and response to treatment in an italian cohort of FH patients: A retrospective analysis

Atherosclerosis, 2017-08, Vol.263, p.e238-e238

2017

Link zum Volltext

Verfügbarkeit prüfen

Statin Intolerance Can be Monitored by Plasma Eicosanoid Assays

Journal of clinical lipidology, 2013-05, Vol.7 (3), p.265-265

2013

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients

Annals of medicine (Helsinki), 2007, Vol.39 (4), p.306-311

2007

Link zum Volltext

Verfügbarkeit prüfen

Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals

British journal of nutrition, 2012-04, Vol.107 (8), p.1176-1183

2012

Link zum Volltext

Verfügbarkeit prüfen

Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study

Journal of internal medicine, 2021-07, Vol.290 (1), p.116-128

2021

Link zum Volltext

Verfügbarkeit prüfen

Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults

Atherosclerosis, 2023-10, Vol.383, p.117314-117314, Article 117314

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical response to statins: Mechanism(s) of variable activity and adverse effects

Annals of medicine (Helsinki), 2012-08, Vol.44 (5), p.419-432

2012

Link zum Volltext

Verfügbarkeit prüfen

Left main coronary wall thickness correlates with the carotid intima media thickness and may provide a new marker of cardiovascular risk

European journal of preventive cardiology, 2019-06, Vol.26 (9), p.1001-1004

2019

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group

Atherosclerosis, 2022-05, Vol.349, p.233-239

2022

Link zum Volltext

Verfügbarkeit prüfen

Cholesteryl ester transfer protein antagonism by drugs--a poor choice

Clinical chemistry (Baltimore, Md.), 2010-10, Vol.56 (10), p.1550-1553

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of a nutraceutical with probiotic and red yeast rice extract in patients with moderate hypercholesterolemia: A randomized, double-blind, placebo-controlled study

Atherosclerosis, 2017-08, Vol.263, p.e109-e109

2017

Link zum Volltext

Verfügbarkeit prüfen

A subgroup analysis of the ODYSSEY APPRISE study: Safety and efficacy of alirocumab in the Italian cohort

Nutrition, metabolism, and cardiovascular diseases, 2022-11, Vol.32 (11), p.2638-2646

2022

Link zum Volltext

Verfügbarkeit prüfen

The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group

Frontiers in genetics, 2022-06, Vol.13, p.912510-912510

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: a randomized, double-blind, placebo controlled study

Drug design, development and therapy, 2017-05, Vol.11, p.1585-1592

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study

Influence of body variables in the development of metabolic syndrome-A long term follow-up study

Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination ( Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)

Effects of a lupin protein concentrate on lipids, blood pressure and insulin resistance in moderately dyslipidaemic patients: A randomised controlled trial

Nutraceutical approach to moderate cardiometabolic risk: Results of a randomized, double-blind and crossover study with Armolipid Plus

Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation

Correction to: Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study

Indicators of Cardiovascular Risk in Metabolic Syndrome: Long Term Follow-up in Italian Patients

Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary prevention

Potential of PCSK9 as a new target for the management of LDL cholesterol

FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders

LDL receptor phenotype and response to treatment in an italian cohort of FH patients: A retrospective analysis

Statin Intolerance Can be Monitored by Plasma Eicosanoid Assays

Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients

Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals

Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study

Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults

Clinical response to statins: Mechanism(s) of variable activity and adverse effects

Left main coronary wall thickness correlates with the carotid intima media thickness and may provide a new marker of cardiovascular risk

Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group

Cholesteryl ester transfer protein antagonism by drugs--a poor choice

Efficacy and safety of a nutraceutical with probiotic and red yeast rice extract in patients with moderate hypercholesterolemia: A randomized, double-blind, placebo-controlled study

A subgroup analysis of the ODYSSEY APPRISE study: Safety and efficacy of alirocumab in the Italian cohort

The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group

Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: a randomized, double-blind, placebo controlled study

Suchergebnisse filtern